Fig. 4From: Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agentsLSM obtained using ARFI in patients with SVR12 and paired measurements at baseline and PW12. LSM, liver stiffness measurement; ARFI, acoustic radiation force impulse elastography; SVR12, sustained virologic response at 12 weeks after therapy; BA, baseline; PW12, 12 weeks after direct-acting antiviral therapy. All comparisons are made with baseline levels. ***P < 0.001Back to article page